Работы, цитирующие эту работу

Работ: 5

Работа: The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   СтатьяTuberculosis Research and EpidemiologyEurosurveillance2013Цитирований: 15

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Обзорная статьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2017Цитирований: 4

   ABIABI:AkademIndex/openalex/2017.review-article.000004

3. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   СтатьяTuberculosis Research and EpidemiologyBMC Medicine2016Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.195695

4. Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

   Stefan Köhler, Damin Asadov, Andreas Bründer +4

   СтатьяTuberculosis Research and EpidemiologyHealth Economics Review2016Цитирований: 2

   ABIABI:AkademIndex/openalex/2016.article.000128

5. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

   Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

   СтатьяTuberculosis Research and EpidemiologyPLoS ONE2018Цитирований: 0

   ABIABI:AkademIndex/openalex/2018.article.000060